Amniocentesis and Fetal Blood Sampling

Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment: Sixth Edition

Volumn , Issue , 2010, Pages 63-93

  Elias, Sherman ^a  

^a Prentice Women's Hospital   (United States)

Author keywords

918 singleton amniocenteses continuous ultrasound guidance; Amniocentesis and fetal blood sampling; Amniocentesis for genetic diagnosis in outpatient facility; Early amniocentesis (EA) alternatives for those desiring prenatal diagnosis; Fetal blood sampling or percutaneous umbilical blood sampling (PUBS); HIV, mother to fetus transmission during amniocentesis; Life threatening maternal risks with amnionitis very rare; Multiple gestations by ultrasonography detection; Rh isoimmunization in amniocentesis; Using amniocentesis hypertonic saline into amniotic sac in pregnancy termination

Indexed keywords

EID: 82355176044     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444314342.ch2     Document Type: Chapter

References (244)

1. Lambl D. Ein seltener fall von hydramnios. Zentralbl Gynaekol 1881;5:329.
2. Schatz F. Eine besondere art von ein seitiger polyhdramnic mit anderseitiger oligohydramnie bei zwillingen. Arch Gynecol 1882;19:392.
3. Menees TD, Miller JD, Holly LE. Amniography:preliminary report. Am J Roentgenol 1930;24:363.
4. Aburel ME. Le declenchement du travail par injections intraamniotique de serum sale hypertonique. Gynecol Obstet 1937;36:398.
5. Gadow EC. Reaching the fetal environment:a tribute to Dr. Herm ógenes Alvarez. Prenat Diagn 1998;18:870.
6. Bevis DCA. The antenatal prediction of haemolytic disease of the newborn. Lancet 1952;1:395.
7. Fuchs F, Riis P. Antenatal sex determination. Nature 1956;117:330.
8. Shettles LB. Nuclear morphology of cells in human amniotic fluid in relation to sex of infant. Am J Obstet Gynecol 1956;71:834.
9. Makowski EL, Prem K, Kaiser IH. Detection of sex of fetuses by the incidence of sex chromatin in nuclei of cells in amniotic fluid. Science 1956;123:542.
10. Steele MW, Breg WR Jr. Chromosome analysis of human amniotic fluid cells. Lancet 1966;1:383.
11. Jacobson CB, Barter RH. Intrauterine diagnosis and management of genetic defects. Am J Obstet Gynecol 1967;99:795.
12. Valenti C, Schutta EJ, Kehaty T. Prenatal diagnosis of Down's syndrome. Lancet 1968;2:220.
13. Nadler HL. Antenatal detection of hereditary disorders. Pediatrics 1968;42:912.
14. Milunsky A. The prenatal diagnosis of hereditary disorders. Springfield, IL:Charles C. Thomas, 1973.
15. Nadler HL, Gerbie AB. Role of amniocentesis in the intrauterine detection of genetic disorders. N Engl J Med 1970;282:596.
16. Littlefield JW. The pregnancy at risk for a genetic disorder. N Engl J Med 1970;282:627.
17. Elias S, Annas GJ. Reproductive genetics and the law. Chicago:Year Book, 1987.
18. Simpson JL, Elias S. Prenatal diagnosis of genetic disorders. In:Creasy RK, Resnik R, eds. Maternal-fetal medicine:principles and practice, 2nd ed. Philadelphia: WB Saunders, 1989:78.
19. Farrell PM, Elias S. Prenatal diagnosis and neonatal screening. In:Gilbert-Barness E, ed. Potter's pathology of the fetus, infant and child, 2nd ed. Philadelphia: Elsevier, 2007:611.
20. Simpson JL, Elias S. Genetics In obstetrics and gynecology, 3rd ed. Philadelphia:WB Saunders, 2003.
21. Shulman LP, Elias S. Techniques for prenatal diagnosis. In:Rimoin DL, Connor JM, Pyeritz RE, Korf BR, eds. Emory and Rimoin's principles and practice of medical genetics, 5th ed. Philadelphia:Elsevier, 2007:679.
22. Shulman LP, Simpson JL, Elias S. Invasive prenatal genetic techniques. In:Sciarra JJ, ed. Gynecology and obstetrics, vol 3. Philadelphia:JB Lippincott, 1992:1.
23. Elias S. Prenatal diagnosis of genetic disorders. In: Givens JR, ed. Endocrinology of pregnancy. Chicago: Year Book, 1980:327.
24. Gerbie AB, Elias S. Technique for midtrimester amniocentesis for prenatal diagnosis. Semin Perinatol 1980;4:159.
25. Gerbie AB, Elias S. Amniocentesis for antenatal diagnosis of genetic defects. Clin Obstet Gynecol 1980;7:5.
26. ACOG. The limits of conscientious refusal in reproductive medicine. ACOG Committee Opinion No 385. Obstet Gynecol 2007;11:1203.
27. Emery AEH. Antenatal diagnosis of genetic disease. Mod Trends Hum Genet 1970;1:267.
28. Scrimegeour JB. Amniocentesis:technique and complications. In:Emery AEH, ed. Antenatal diagnosis of genetic disease. Baltimore:Williams and Wilkins, 1973:11.
29. Tabor A, Philip J, Bang J, et al. Needle size and risk of miscarriage after amniocentesis. Lancet 1988;1:183.
30. Tharmaratnam S, Sadek S, Steele EK, et al. Transplacental early amniocentesis and pregnancy outcome. Br J Obstet Gynaecol 1998;105:228.
31. Bombard AT, Powers JF, Carter SM, et al. Procedure related fetal losses in transplacental versus non-transplacental genetic amniocentesis. Am J Obstet Gynecol 1995;172:868.
32. Gordon M, Ventura-Braswell A, Higby K, Ward J. Does local anesthesia decrease pain perception in women undergoing amniocentesis? Am J Obstet Gynecol 2007;196:55.
33. Van Schoubroeck D, Verhaeghe J. Does local anesthesia at mid-trimester amniocentesis decrease pain experience? A randomized trial in 220 patients. Ultrasound Obstet Gynecol 2000;16:536.
34. Pongrojpaw D, Somprasit C, Chanthasenanont A. The efficacy of lidocaine-prilocaine cream to reduce pain in genetic amniocentesis. J Med Assoc Thai 2007;10:1992.
35. Wax JR, Pinette MG, Carpenter M, Chard R, Blackstone J, Cartin A. Reducing pain with genetic amniocentesis-A randomized trial of subfreezing versus room temperature needles. J Matern Fetal Neonatal Med 2005;18:221.
36. Lekskul N, Tannirandorn Y. The location of needle insertion effect on maternal pain in amniocentesis. J Med Assoc Thai 2006;89 (suppl 4):137.
37. Ferber A, Onyeije CI, Zelop CM, et al. Maternal pain and anxiety in genetic amniocentesis:expectation versus reality. Ultrasound Obstet Gynecol 2002;19:13.
38. Karasahin E, Gungor S, Goktolga U, Keskin U, Gezginc K, Baser I. Anticipated and perceived pain from midtrimester amniocentesis. Int J Gynecol Obstet 2008;101:290.
39. Dolkart L, Harter M, Snyder M. Four-dimensional ultrasonographic guidance for invasive obstetric procedures. J Ultrasound Med 2005;24:1261.
40. Sikkema-Raddatz B, van Echten J, van der Vlag J, et al. Minimal volume of amniotic fluid for reliable prenatal cytogenetic diagnosis. Prenat Diagn 2002;22:164.
41. Guven M, Ceylaner G, Coskun A. Volume of sampled amniotic fluid and prenatal cytogenetic diagnosis. Int J Gynecol Obstet 2006;95:157.
42. Welch RA, Salem-Elgharib S, Wiktor A, Van Dyke D, Blessed W. Operator experience and sample quality in genetic amniocentesis. Am J Obstet Gynecol 2006;194:189.
43. Borrell A, Borobio V, Hernandez S, Cobo T, Arigita M, Sanchez A. Vacuum container aspiration as a new technique for genetic amniocentesis. Prenat Diagn 2008;28:962.
44. NICHD National Registry for Amniocentesis Study Group. Midtrimester amniocentesis for prenatal diagnosis: safety and accuracy. JAMA 1976;236:1471.
45. Simpson NE, Dallaire L, Miller JR, et al. Prenatal diagnosis of genetic disease in Canada:report of a collaborative study. Can Med Assoc J 1976;15:739.
46. Finberg HJ, Frigoletto FD. Sonographic demonstration of uterine contraction during amniocentesis. Am J Obstet Gynecol 1981;139:740.
47. Platt LD, Devore GR, Gim OV, et al. Failed amniocentesis: the role of membrane tenting. Am J Obstet Gynecol 1982;144:479.
48. Golbus MS, Loughman WD, Epstein CJ, et al. Prenatal diagnosis in 3000 amniocenteses. N Engl J Med 1979;300:157.
49. Romero R, Jeanty P, Reece EA, et al. Sonographically monitored amniocentesis to decrease intraoperative complications. Obstet Gynecol 1985;65:426.
50. Tabor A, Philip J, Madsen MI, et al. Randomized controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986;1:1287.
51. Elias S, Simpson JL. (unpublished data).
52. Pirani BBI, Doran TA, Benzie RJ. Amniotic fluid or maternal urine? Lancet 1976;1:303.
53. Guibaud S, Bonnet M, Dury A. Amniotic fluid or maternal uterine? Lancet 1976;1:746.
54. Elias S, Martin AO, Patel VA, et al. Analysis for amniotic fluid crystallization in second-trimester amniocentesis. Am J Obstet Gynecol 1979;133:401.
55. Pittini R, Oepkes D, Macrury K, et al. Teaching invasive perinatal procedures:assessment of a high fidelity simulator-based curriculum. Ultrasound Obstet Gynecol 2002;19:478.
56. Forest C, Comas O, Vaysiere C, Soler L, Marescaux J. Ultrasound and needle insertion simulators built on real patient-based data. In:Westwood JD, Hoffman HM, eds. Medicine meets virtual reality. Stud Health Technol In form 2007:136.
57. Zubair I, Marcotte MP, Weinstein L, Brost BC. A novel amniocentesis model for learning stereotactic skills. Am J Obstet Gynecol 2006;194:846.
58. Anderson RL, Goldberg JD. Prenatal diagnosis in multiple gestations:20 years'experience with amniocentesis. Prenat Diagn 1991;11:263.
59. Van Vugt JM, Nieuwint A, van Geijn HP. Single-needle insertion:n alternative technique for early second trimester genetic twin amniocentesis. Fetal Diagn Ther 1995;10:178.
60. Buscaglia M, Ghisoni L, Bellotti M, et al. Genetic amniocentesis in biamniotic twin pregnancies by a single insertion of the needle. Prenat Diagn 1995;15:17.
61. Jeanty P, Shah D, Roussis P. Single-needle insertion in twin gestations. J Ultrasound Med 1990;9:5111.
62. Henrion R, Papa F, Rouvillois JL, et al. L'amniocentese precoce en cas de grossesse gemellaire. Nouv Press Med 1978;7:4119.
63. Benacerraf BR, Frigoletto FD. Amniocentesis under continuous ultrasound guidance:a series of 232 cases. Obstet Gynecol 1983;62:760.
64. Williamson RA, Vamer MW, Grant SS. Reduction in amniocentesis risks using a real-time needle guide procedure. Obstet Gynecol 1985;65:751.
65. Cruikshank DP, Vamer MW, Cruikshank JE, et al. Midtrimester amniocentesis:an analysis of 923 cases with neonatal follow-up. Am J Obstet Gynecol 1983;146:204.
66. Andreasen E, Kristoffersen K. Incidence of spontaneous abortion after amniocentesis:influence of placental localization and gynecologic history. Am J Perinatol 1989;6:268.
67. Salvador E, Bienstock J, Blakemore KJ, et al. Leiomyomata uteri, genetic amniocentesis, and the risk of sec ond-trimester spontaneous abortion. Am J Obstet Gynecol 2002;186:913.
68. MacGillivary I, Nylander POS, Corney G, et al. Human multiple reproduction. London:WB Saunders, 1975.
69. March CM. Improved pregnancy rate with monitoring of gonadotrophin therapy by three modalities. Am J Obstet Gynecol 1987;156:1473.
70. Dawson KJ, Rutherford AJ, Margara RA, et al. Reducing triplet pregnancies following in-vitro fertilisation. Lancet 1991;337:1543.
71. Society for Assisted Reproductive Technology. Assisted reproductive techniques in the United States and Canada:1993 results generated from the American Society for Reproductive Medicine/Society for Reproductive Technology Registry. Fertil Steril 1995;64:13.
72. Jones HW Jr. Multiple births:how are we doing? Fertil Steril 2003;79:17.
73. Waterhouse JAH. Twinning in twin pedigrees. Br J Soc Med 1950;4:197.
74. Bulmer MG. Twinning rate in Europe during the war. BMJ 1959;1:29.
75. Myrianthopoulos N. An epidemiologic survey of twins in a large, prospectively studied population. Am J Hum Genet 1970;22:611.
76. Allen G, Baroff GS. Mongoloid twins and their siblings. Acta Genet 1955;5:294.
77. Zellweger H. Familial aggregates of the 21-trisomy syndrome. Ann NY Acad Sci 1968;155:784.
78. Rodis JF, Egan JRX, Craffey A, et al. Calculated risk of chromosomal abnormalities in twin gestations. Obstet Gynecol 1990;76:1037.
79. Meyers C, Adam R, Dungan J, et al. Aneuploidy in twin gestations:when is maternal age advanced? Obstet Gynecol 1997;89:248.
80. Elias S, Gerbie A, Simpson JL. Genetic amniocentesis in twin gestations. Am J Obstet Gynecol 1980;138:169.
81. Kidd SA, Lancaster PAL, Anderson JC, et al. Fetal death after exposure to methylene blue dye during mid-trimester amniocentesis in twin pregnancy. Prenat Diagn 1996;16:39.
82. Henry G, Robinson A. Genetic amniocentesis in twin pregnancies. Am J Hum Genet 1975;30:695.
83. Wolfe DA, Scheible FW, Young FE, et al. Genetic amniocentesis in multiple pregnancy. J Clin Ultrasound 1979;7:208.
84. Jassani MN, Merkatz IR, Brennan IN, et al. Twin pregnancy with discordance for Down's syndrome. Obstet Gynecol 1980;55(suppl):455.
85. Bovicelli L, Michelacci L, Rizzo N, et al. Genetic amniocentesis in twin pregnancy. Prenat Diagn 1983;3:83.
86. Goldstein AI, Stills SM. Midtrimester amniocentesis in twin pregnancies. Am J Obstet Gynecol 1983;62:659.
87. Palle C, Anderson JW, Tobar A, et al. Increased risk of abortion after genetic amniocentesis in twin pregnancies. Prenat Diagn 1983;3:83.
88. Taylor MB, Anderson RL, Golbus MS. One hundred twin pregnancies in a prenatal diagnosis program. Am J Med Genet 1984;148:585.
89. Filkins K, Russo J. Genetic amniocentesis in multiple gestations. Prenat Diagn 1984;4:223.
90. Librach CL, Doran TA, Benzie RJ, et al. Genetic amniocentesis in seventy twin pregnancies. Am J Obstet Gynecol 1984;148:585.
91. Pijpers L, Jahoda MG, Vosters RP, et al. Genetic amniocentesis in twin pregnancies. Br J Obstet Gynaecol 1988;95:323.
92. Simpson JL. Procedures for prenatal diagnosis of genetic disorders. In:Golbus SG, Simpson JL, eds. Genetics in obstetrics and gynecology, 2nd ed. Philadelphia: WB Saunders, 1992.
93. Dacus JV, Wilroy RS, Summitt RL, et al. Genetic amniocentesis: a twelve years'experience. Am J Med Genet 1985;20:443.
94. Yukobowich E, Anteby EY, Cohen SM, et al. Risk of fetal loss in twin pregnancies undergoing second trimester amniocentesis (1). Obstet Gynecol 2001;98:231.
95. Millaire M, Bujold E, Morency AM, Gauthier RJ. Mid-trimester genetic amniocentesis in twin pregnancy and the risk of fetal loss. J Obstet Gynaecol Can 2006;28:512.
96. Ghidini A, Lynch L, Hicks C, Alvarez M, Lockwood CJ. The risk of second-trimester amniocentesis in twin gestations:a case-control study. Am J Obstet Gynecol 1993;169:1013.
97. Weisz B, Rodeck CH. Invasive diagnostic procedures in twin pregnancies. Prenat Diagn 2005;25:751.
98. Rochon M, Eddleman K, Stone J. Invasive procedures in multifetal pregnancies. Clin Perinatol 2005;32:355.
99. Appelman Z, Furman B. Invasive genetic diagnosis in multiple pregnancies. Obstet Gynecol Clin North Am 2005;32:97.
100. Bhide A, Thilaganathan B. What prenatal diagnosis should be offered in multiple pregnancy? Best Pract Res Clin Obstet Gynaecol 2004;18:531.
101. Toth-Pal E, Ban Z, Papp C, Beke A, Papp Z. Genetic amniocentesis in twin pregnancy-experience of eleven years. Orv Hetil 2004;145:1127.
102. Toth-Pal E, Papp C, Beke A, Ban Z, Papp Z. Genetic amniocentesis in multiple pregnancy. Fetal Diagn Ther 2004;19:138.
103. Working Party on Amniocentesis. An assessment of hazards of amniocentesis. Br J Obstet Gynaecol 1978;85(suppl 2):1.
104. Hill LM, Platt LD, Collage B. Rh-sensitization after genetic amniocentesis. Obstet Gynecol 1980;56:459.
105. Golbus MS, Stephens JD, Can HM, et al. Rh-isoimmunization following genetic amniocentesis. Prenat Diagn 1982;2:149.
106. Wyskowski DK, Flynt JW, Goldberg MF, et al. Rh hemolytic disease:epidemiologic surveillance in the United States, 1968 to 1975. JAMA 1979;242:1376.
107. Khalil MA, Tabsh MA, Lobherz TB, et al. Risks of prophylactic anti-D immunoglobulin after second-trimester amniocentesis. Am J Obstet Gynecol 1984;149:225.
108. Murray JC, Kasarp LE, Williamson RA, et al. Rh isoimmunization related to amniocentesis. Am J Med Genet 1983;16:527.
109. Tabor A, Jerne D, Bok JE. Incidence of rhesus immunization after genetic amniocentesis. BMJ 1986;293:533.
110. Gorman JG. New applications of Rh immune globulin: effect on protocols. In:Frigoletto FD Jr, Jewett JR, Konugres AA, eds. Rh hemolytic disease:new strategy for eradication. Boston:GK Hall, 1981:199.
111. Frigoletto FD Jr. Risk perspectives of Rh sensitization. In:Frigoletto FD Jr, Jewett JF, Konugres AA, eds. Rh hemolytic disease:new strategy for eradication. Boston: GK Hall, 1981:103.
112. Pollack W, Gorman JG., Freda VI. Rh immune suppression: past, present, and future. In:Frigoletto FD Jr, Jewett JF, Konugres AA, eds. Rh hemolytic disease:new strategy for eradication. Boston:GK Hall, 1981:9.
113. Miles JH, Kaback MD. Rh immune globulin after genetic amniocentesis. Clin Genet Res 1979;27:103A.
114. Crane JP, Rohland B, Larson D. Rh immune globulin after genetic amniocentesis:impact on pregnancy outcome. Am J Med Genet 1984;19:763.
115. ACOG. Prevention of RhD Isoimmunization. ACOG Practice Bulletin No 4. Washington, DC:American College of Obstetricians and Gynecologists.
116. Turnbull AC, MacKenzie IZ. Second-trimester amniocentesis and termination of pregnancy. Br Med Bull 1983;39:315.
117. Karp LE, Schiller HS. Meconium staining of amniotic fluid at midtrimester amniocentesis. Obstet Gynecol 1977;50:475.
118. Hankins GD, Rowe J, Quirk JG, et al. Significance of brown and/or green amniotic fluid at the time of second trimester genetic amniocentesis. Obstet Gynecol 1984;64:353.
119. Zorn EM, Hanson FW, Greve LC, et al. Analysis of the significance of discolored amniotic fluid detected at mid-trimester amniocentesis. Am J Obstet Gynecol 1986;154:1234.
120. Odibo AO, Gray DL, Dicke JM, Stamilio DM, Macones GA, Crane JP, eds. Revisiting the fetal loss rate after second-trimester genetic amniocentesis:a single center's 16-year experience. 17th Annual Meeting of the International Society for Ultrasound in Obstetrics and Gynecology, March 2008, Florence, Italy. Washington, DC:American College of Obstetricians and Gynecologists.
121. Murken JA, Stengel-Rutowski S, Schwinger E, eds. Prenatal diagnosis. Proceedings of the Third European Conference on Prenatal Diagnosis of Genetic Disorders. Stuttgart:Ferdinand Enke, 1979:132.
122. Proceedings of the National Institute of Child Health and Human Development Consensus Conference on Antenatal Diagnosis, December 1979. Washington, DC:Government Printing Office, 1979. NIH Publication no. 80-1973.
123. Bell JA, Pearn JH, Wilson BH, Ansford AJ. Prenatal cytogenetic diagnosis-a current audit. A review of 2000 cases of prenatal cytogenetic diagnoses after amniocentesis, and comparisons with early experience. Med J Aust. 1987;146:12.
124. Ayadi S, Carbillon L, Varlet C, Uzan M, Pourriat JL. Fatal sepsis due to Escherichia coli after second-trimester amniocentesis. Fetal Diagn Ther 1998;13:98.
125. Elchalal U, Shachar IB, Peleg D, Schenker JG. Maternal mortality following diagnostic 2nd-trimester amniocentesis. Fetal Diagn Ther 2004;19:195.
126. Thorp JA, Helfgott AW, King EA, King AA, Minyard AN. Maternal death after second-trimester genetic amniocentesis. Obstet Gynecol 2005;105 (5, Part 2): 1213.
127. Thomas IT, Smith DW. Oligohydramnios, cause of the nonrenal features of the Potter's syndrome, including pulmonary hypoplasia. J Pediatr 1974;84:811.
128. Simpson JL, Socol ML, Aladjem S, et al. Normal fetal growth despite persistent amniotic fluid leakage after genetic amniocentesis. Prenat Diagn 1981;1:277.
129. Crane JP, Rohland BM. Clinical significance of persistent amniotic fluid leakage after genetic amniocentesis. Prenat Diagn 1986;6 (1):25.
130. Sipurzynski-Budrass S, Macher S, Haeusler M, Lanzer G. Successful treatment of premature rupture of membranes after genetic amniocentesis by intra-amniotic injection of platelets and cryoprecipitate (amniopatch): a case report. Vox Sang 2006;91:88.
131. Contino B, Armellino F, Brokaj L, Patroncini S. Amniopatch, a repairing technique for premature rupture of amniotic membranes in second trimester. Acta Bio Medica Ateneo Parmense 2004;75(suppl 1):27.
132. Lamb MP. Gangrene of a fetal limb due to amniocentesis. Br J Obstet Gynaecol 1975;82:829.
133. Karp LE, Hayden PW. Fetal puncture during mid-trimester amniocentesis. Obstet Gynecol 1977;49:115.
134. Rickwood AMK. A case of ileal atresia and ileocutaneous fistula caused by amniocentesis. J Pediatr 1977;1:720.
135. Eply SL, Hanson JW, Cruikshank DP. Fetal injury with midtrimester diagnostic amniocentesis. Obstet Gynecol 1979;53:77.
136. Swift PFG, Driscoll IB, Vovles KDJ. Neonatal small bowel obstruction associated with amniocentesis. BMJ 1979;1:720.
137. Youroukos S, Papadelis F, Matsaniotis N. Porencephalic cysts after amniocentesis. Arch Dis Child 1980;55:814.
138. Merin S, Byth Y. Uniocular congenital blindness as a complication of midtrimester amniocentesis. Am J Ophthalmol 1980;80:299.
139. Isenberg SJ, Heckenlively JR. Traumatized eye with retinal damage from amniocentesis. J Pediatr Ophthalmol Strabismus 1988;25:196.
140. Adrnoni MM, Ben Ezra D. Ocular trauma following amniocentesis as the cause of leukocoria. J Pediatr Opthalmol Strabismus 1988;25:196.
141. Gounot E, Cuzin B, Louis D, et al. Fistule peritoneo-parietale au decours d'une amniocentese precoce:a propos d'un cas. Revue de la literature. Chir Pediatr 1989;30:52.
142. Mancini J, Lethel V, Hugonenq C, et al. Brain injuries in early foetal life:consequences for brain development. Dev Med Child Neurol 2001;43:52.
143. Fines B, Ben-Ami TE, Yousefzadeh DK. Traumatic prenatal sigmoid perforation due to amniocentesis. Pediatr Radiol 2001;31:440.
144. DeLong GR. Mid-gestation right basal ganglia lesion: clinical observations in two children. Neurology 2002;59:54.
145. Vilar Coromina N, Vicente Villa A, Puigarnau Vallhonrat R, Vela Martinez A, Gonzalez Ensenat MA. Skin dimpling:a complication of amniocentesis. An Pediatr (Barc) 2007;66:4.
146. Medical Research Council. Diagnosis of genetic disease by amniocentesis during the second trimester of pregnancy. Ottawa:Medical Research Council, 1977.
147. Wald NJ, Terzian E, Vickers PA, et al. Congenital talipes and hip malformation in relation to amniocentesis: a case-control study. Lancet 1983;2:246.
148. Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1:the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol 1996;175:661.
149. Bucceri AM, Somigliana E, Vignali M. Early invasive diagnostic techniques during pregnancy in HIV-infected women. Acta Obstet Gynecol Scand 2001;80:82.
150. de Decker HP. Mother-to-fetus HIV transmission during amniocentesis-ethical concerns. S Afr Med J 2002;92:124.
151. International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. N Engl J Med 1999;179:590.
152. Somigliana E, Bucceri AM, Tibaldi C, et al. Early invasive diagnostic techniques in pregnant women who are infected wtih the HIV:a multicenter case series. Am J Obstet Gynecol 2005;193:437.
153. Ekoukou D, Khuong-Josses M, Ghibaudo N, Mechali D, Rotten D. Amniocentesis in pregnant HIV-infected patients:absence of mother-to-child viral transmission in a series of selected patients. Eur J Obstet Gynecol Reprod Biol 2008;140:212.
154. Stein Z, Kline J, Susser E, et al. Maternal age and spontaneous abortion. In:Porter IH, Hook EB, eds. Human embryonic and fetal death. New York:Academic Press, 1980:107.
155. Simpson JL. Incidence and timing of pregnancy losses: relevance to evaluating safety of early prenatal diagnosis. Am J Med Genet 1990;35:165.
156. Christiaens GCML, Stoutenbeek PH. Spontaneous abortion in proven intact pregnancies. Lancet 1984;2:572.
157. Wilson RD, Kendrick V, Wittman BK, et al. Risks of spontaneous abortion in ultrasonographically normal pregnancies. Lancet 1984;2:290.
158. Tongsong T, Wanapirak C, Sirivatanapa P, et al. Amniocentesis-related fetal loss:a cohort study. Obstet Gynecol 1998;92:64.
159. Papantoniou NE, Daskalakis GJ, Tziotis JG, et al. Risk factors predisposing to fetal loss following a second trimester amniocentesis. Br J Obstet Gynaecol 2001;108:1053.
160. Eddleman KA, Malone FD, Sullivan L, et al. Pregnancy loss rates after midtrimester amniocentesis by the First And Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. Obstet Gynecol 2006;109 (2, Part 1):1067.
161. Nadel A. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2007;109 (2, Part 1):451.
162. Wilson R. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2007;109 (2, Part 1):451.
163. Smith L. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2007;109 (2, Part 1):452.
164. Nicolaides K. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2007;109 (2, Part 1):780.
165. Alfirevic Z, Tabor A. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2007;109:1203.
166. Armstrong J, Cohen AW, Bombard AT, et al. Comparison of amniocentesis-related loss rates between obstetrician-gynecologists and perinatologists. Obstet Gynecol 2002;99:65S.
167. Henry GP, Miller WA. Early amniocentesis. J Reprod Med 1992;37:396.
168. Hanson FW, Zorn EM, Tennant FR. Amniocentesis before 15 weeks'gestation:outcome, risks, and technical problems. Am J Obstet Gynecol 1987;156:1524.
169. Evans MI, Grogan A, Koppitch MS III, et al. Genetic diagnosis in the first trimester:the norm for the 1990s. Am J Obstet Gynecol 1989;160:1332.
170. Elejalde BR, de Elejalde MM, Acuna JM. Prospective study of amniocentesis performed between weeks 9 and 16 of gestation:its feasibility, risks, complications and use in early genetic prenatal diagnosis. Am J Med Genet 1990;35:188.
171. Bombard T, Rigdon DT. Prospective pilot evaluation of early (11-14 weeks'gestation) amniocentesis in 75 patients. Mil Med 1992;157:339.
172. Calhoun BC, Brehm W, Bombard AT. Early genetic amniocentesis and its relationship to respiratory difficulties in paediatric patients:a report of findings in patients and matched controls 3-5 years post-procedure. Prenat Diagn 1994;14:209.
173. Stripparo L, Buscaglia M, Longatti L. Genetic amniocentesis: 505 cases performed before the sixteenth week of gestation. Prenat Diagn 1990;10:359.
174. Penso CA, Sandstrom MM, Garber MF, et al. Early amniocentesis:report of 407 cases with neonatal follow-up. Obstet Gynecol 1990;76:1032.
175. Hackett GA, Smithill, Rebello CTH, et al. Early amniocentesis at 11-14 weeks gestation for the diagnosis of fetal chromosomal abnormality:a clinical evaluation. Prenat Diagn 1991;11:311.
176. Bombard AT, Carter SM, Nitowsky HM. Early amniocentesis versus chorionic villus sampling for fetal karotyping. Lancet 1994;344:826.
177. Brumfield CG, Lin S, Conner W, et al. Pregnancy outcome following genetic amniocentesis at 11-14 versus 16-19 weeks'gestation. Obstet Gynecol 1996;88:114.
178. Wilson RD, Johnson J, Dansereau J. Pregnancy outcome following genetic amniocentesis at 11-14 versus 16-19 weeks'gestation. Obstet Gynecol 1996;88:638.
179. Shulman LP, Elias S, Phillips OP, et al. Amniocentesis performed at 14 weeks gestation or earlier:comparison with first-trimester chorionic villus sampling. Obstet Gynecol 1994;83:543.
180. Bravo RR, Shulman LP, Phillips OP, et al. Transplacental needle passage in early amniocentesis and pregnancy loss. Obstet Gynecol 1995;86:437.
181. Shulman LP, Elias S, Phillips OP, et al. Early twin amniocentesis prior to 14 weeks gestation. Prenat Diagn 1992;12:625.
182. Diaz Vega M, De La Cueva P, Leal C, et al. Early amniocentesis at 10-12 weeks'gestation. Prenat Diagn 1996;16:307.
183. Rao N, Pettenati M, Barry M, et al. Early amniocentesis: a cytogenetic evaluation of 1010 consecutive cases. Am J Hum Genet 1990;47:A 283.
184. Nicolaides KH, Brizot ML, Patel F, et al. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks gestation. Lancet 1994;344:435.
185. Vandenbussche FPHA, Kanhai HHH, Keirse MJNC. Safety of early amniocentesis. Lancet 1994;344:1032.
186. Simpson JL. Genetic counseling and prenatal diagnosis. In:Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics: normal and problem pregnancies, 3rd ed. New York:Churchill Livingstone, 1996:215.
187. Johnson J, Wilson RD, Windsor EJT, et al. The Early Amniocentesis Study:a randomized clinical trial of early amniocentesis versus midtrimester amniocentesis. Fetal Diagn Ther 1996;11:85.
188. Canadian Early and Mid-Trimester Amniocentesis Trial Group. Randomized trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet 1998;351:242.
189. Johnson JM, Wilson RD, Singer J, et al. Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian Early (EA) versus Mid-trimester (MA) Amniocentesis Trial. Prenat Diagn 1999;19:732.
190. Sundberg K, Bang J, Smidt-Jensen S, et al. Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet 1997;350:697.
191. Philip J, for the NICHD EATA Study Group. Greater risk associated with early amniocentesis compared to chorionic villus sampling:an international randomized trial. Am J Obstet Gynecol 2002;187:39A.
192. ACOG. Invasive prenatal testing for aneuploidy. ACOG Practice Bulletin No 88. Obstet Gynec 2007;110(6):1459.
193. Elias S. The role of fetoscopy in antenatal diagnosis. Clin Obstet Gynecol 1980;7:73.
194. Hobbins JC, Mahoney MJ. In utero diagnosis of hemoglobinopathies: technique for obtaining fetal blood. N Engl J Med 1974;290:1065.
195. Gosden C, Nicolaides KH, Rodeck CH. Fetal blood sampling in investigation of chromosome mosaicism in amniotic fluid culture. Lancet 1988;2:613.
196. Tipton RE, Therapel AT, Chang HT, et al. Rapid chromosome analysis using spontaneously dividing cells from umbilical cord blood (fetal and neonatal). Am J Obstet Gynecol 1990;161:1546.
197. Liou JD, Chen CP, Breg WR, et al. Fetal blood sampling and cytogenetic abnormalities. Prenat Diagn 1993;13:1.
198. Porreco RP, Harshbarger B, McGavran L. Rapid cytogenetic assessment of fetal blood samples. Obstet Gynecol 1993;82:242.
199. Ryan G, Rodeck CH. Fetal blood sampling. In:Simpson JL, Elias S, eds. Essentials of prenatal diagnosis. New York:Churchill Livingstone, 1993:63.
200. Daffos F. Fetal blood sampling. Annu Rev Med 1989;40:319.
201. Forestier F, Daffos F, Rainau M, et al. Blood chemistry of normal human fetuses at midtrimester of pregnancy. Pediatr Res 1987;21:579.
202. Forestier F, Cox WL, Daffos F, et al. The assessment of fetal blood samples. Am J Obstet Gynecol 1988;158:1184.
203. Nicolaides KH, Clewel WH, Rodeck CH. Measurement of human fetoplacental blood volume in erythroblastosis fetalis. Am J Obstet Gynecol 1987;157:50.
204. Pardi G, Marconi M, Cetin I, et al. Fetal blood sampling during pregnancy:risks and diagnostic advantages. J Perinat Med 1994;22:513.
205. Bahado-Singh RO, Morotti R, Pirhonen J, et al. Invasive techniques for prenatal diagnosis:current concepts. J Assoc Acad Minority Phys 1995;6:28.
206. Tongsong T, Wanapirak C, Pkunavikatikul C, et al. Fetal loss rate associated with cordocentesis at midgestation. Am J Obstet Gynecol 2001;184:719.
207. Donnenfeld AE, Wiseman B, Lavi E, et al. Prenatal diagnosis of severe combined immunodeficiency. J Pediatr 1990;10:29.
208. Udom-Rice I, Bussel JB. Fetal and neonatal thrombocytopenia. Blood Rev 1995;9:57.
209. Bussel JB, Berkowitz RL, Mcfarland JG, et al. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 1988;319:1374.
210. Weiner CP. Cordocentesis for diagnostic indications: two years experience. Obstet Gynecol 1987;70:664.
211. Durandy A, Dumez Y, Guy-Grand D, et al. Prenatal diagnosis of severe combined immunodeficiency. J Pediatr 1982;101:995.
212. Holmberg L, Gustavii B, Jonsson A. A prenatal study of fetal platelet count and size with application to fetus at risk for Wiskott-Aldrich syndrome. J Pediatr 1983;102:773.
213. Diukman R, Tanigawa S, Cowan MJ, et al. Prenatal diagnosis of Chediak-Higashi syndrome. Prenat Diagn 1992;12:1877.
214. Rodeck CH, Nicolini U. Fetal blood sampling. Eur J Obstet Gynecol Reprod Biol 1988;28:85.
215. Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988;318:271.
216. Peters MT, Nicolaides KH. Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet Gynecol 1990;75:501.
217. Hsieh PI, Ko TM, Chang FM, et al. Percutaneous ultrasound-guided fetal blood sampling:experience in the first 100 cases. Taiwan I Hsueh Hui Tsa Chi 1989;88:137.
218. Viscarello RR, Cullen MT, DeGennaro NJ, et al. Fetal blood sampling in human immunodeficiency virus seropositive women. Am J Obstet Gynecol 1992;167:1075.
219. Newton ER. Diagnosis of perinatal TORCH infections. Clin Obstet Gynecol 1999;42:59.
220. Azam AZ, Vial Y, Fawer CL, et al. Prenatal diagnosis of congenital cytomegalovirus infection. Obstet Gynecol 2001;97:443.
221. Kailasam C, Brennand J, Cameron AD. Congenital parvovirus B19 infection:experience of a recent epidemic. Fetal Diagn Ther 2001;16:18.
222. Moise KJ, Deter RL, Kirshon B, et al. Intravenous pancuronium bromide for fetal neuromuscular blockade during intrauterine transfusion for red cell alloimmunization. Obstet Gynecol 1989;74:905.
223. Bellini P, Marinetti E, Arreghini A, et al. Treatment of maternal hyperthyroidism and fetal goiter. Minerva Ginecol 2000;52:25.
224. Gruner C, Kollert A, Wildt L, et al. Intrauterine treatment of fetal goitrous hypothyroidism controlled by determination of thyroid-stimulating hormone in fetal serum. A case report and review of the literature. Fetal Diagn Ther 2001;16:47.
225. Calderwood C, Williams H, Campbell IW, et al. Cordocentesis to predict fetal outcome after administration of radioactive iodine for Graves'disease. J Obstet Gynaecol 2002;22:217.
226. Orlandi F, Damiani G, Jakil C, et al. The risks of early cordocentesis (12-21 weeks):analysis of 500 procedures. Prenat Diagn 1990;10:425.
227. Chinaiya A, Venkat A, Dawn C, et al. Intrahepatic vein fetal blood sampling:current role in prenatal diagnosis. J Obstet Gynaecol Res 1998;24:239.
228. Nicolini U, Nicolaides KH, Fisk NM, et al. Fetal blood sampling from the intrahepatic vein:analysis of safety and clinical experience with 214 procedures. Obstet Gynecol 1990;76:47.
229. Kim SR, Won HS, Lee PR, Kim A. Four-dimensional ultrasound guidance of prenatal invasive procedures. Ultrasound Obstet Gynecol 2005;26:663.
230. Kawakami Y, Matsuda H, Shibasaki T, Yoshida M, Furuya K. Safer cordocentesis by new 25-gauge needles. Fetal Diagn Ther 2008;24:211.
231. Nicolini U, Kochenour NK, Greco P, et al. Consequences of fetomatemal hemorrhage after intrauterine transfusion. BMJ 1988;297:1379.
232. Ghidini A, Sepulveda W, Lockwood CJ, et al. Complications of fetal blood sampling. Am J Obstet Gynecol 1993;168:1339.
233. Wilson RD, Farquarhson DF, Wittman BK, et al. Cordocentesis: overall pregnancy loss rate as important as procedure loss rate. Fetal Diagn Ther 1994;9:142.
234. Buscaglia M, Ghisoni L, Bellotti M, et al. Percutaneous umbilical blood sampling:indication, changes, and procedure loss rates in nine years'experience. Fetal Diagn Ther 1996;11:106.
235. Weiner CP, Okamura K. Diagnostic fetal blood sampling-technique related losses. Fetal Diagn Ther 1996;11:169.
236. Liao C, Wei J, Li Q, et al. Efficacy and safety of cordocentesis for prenatal diagnosis. Int J Gynecol Obstet 2006;93:13.
237. Antsaklis A, Daskalakis G, Papantoniou N, et al. Fetal blood sampling-indication-related losses. Prenat Diagn 1998:18:934.
238. Sikovanyecz J, Horvath E, Sallay E, et al. Fetomaternal transfusion and pregnancy outcome after cordocentesis. Fetal Diagn Ther 2001;16:83.
239. Van Selm M, Kanhai HHH, Van Loon J. Detection of fetomatemal hemorrhage associated with cordocentesis using serum alpha-fetoprotein and the Kleihauer technique. Prenat Diagn 1995;15:313.
240. Rujiwetpongstorn J, Tongsong T, Wanapirak C, et al. Feto-maternal hemorrhage after cordocentesis at Maharaj Nakorn Chiang Mai Hospital. J Med Assoc Thai 2005;88:145.
241. Tongprasert F, Tongsong T, Wanapirak C, et al. Cordocentesis in multifetal pregnancies. Prenat Diagn 2007;27:1100.
242. Abdel-Fattah SA, Bartha JL, Kyle PM, et al. Safety of fetal blood sampling by cordocentesis in fetuses with single umbilical arteries. Prenat Diagn 2004;24:605.
243. Chan J, Kumar S, Fisk NM. First trimester embryo-fetoscopic and ultrasound-guided fetal blood sampling for ex vivo viral transduction of cultured human fetal mesenchymal stem cells. Hum Reprod 2008;23: 2427.
244. Sarno AP Jr, Wilson RD. Fetal cardiocentesis:a review of indications, risks, applications and technique. Fetal Diagn Ther 2008;23:237.